Ackermann, M., Kempf, H., Hetzel, M., Hesse, C., Hashtchin, A. R., Brinkert, K., . . . Lachmann, N. (2018). Bioreactor-based mass production of human iPSC-derived macrophages enables immunotherapies against bacterial airway infections. Nature Portfolio.
Chicago Style (17th ed.) CitationAckermann, Mania, et al. Bioreactor-based Mass Production of Human IPSC-derived Macrophages Enables Immunotherapies Against Bacterial Airway Infections. Nature Portfolio, 2018.
MLA (8th ed.) CitationAckermann, Mania, et al. Bioreactor-based Mass Production of Human IPSC-derived Macrophages Enables Immunotherapies Against Bacterial Airway Infections. Nature Portfolio, 2018.
Warning: These citations may not always be 100% accurate.